Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Transparency
AstraZeneca to Reveal HCP Payments Worldwide
Earlier this month, pharmaceutical powerhouse AstraZeneca announced that it would disclose all payments to healthcare providers in…
Vermont Passes Manufacturer and Insurer Pharmaceutical Cost Transparency…
On May 30th, Vermont Governor Phil Scott (R) signed Senate Bill 92 into law (now, Act 193). A law that adds new reporting…
Senator McCaskill Introduces: The Patient Advocacy Transparency Act of 2018
As a follow-up to Senator Claire McCaskill’s long running opioid investigation and report titled: Fueling an Epidemic: Exposing…
Connecticut’s New Drug Pricing Law Requires Transparency from PBMs, Health…
On May 31st, Connecticut’s governor Daniel Malloy signed into law Substitute House Bill 5384, which imposes cost disclosure and…
12th Annual Transparency and Aggregate Spend Conference
The Twelfth Annual Transparency and Aggregate Spend Conference is scheduled for August 20th – 22nd, 2018, at the Ritz-Carlton in…
Bipartisan Trio of Senators Introduces New Open Payments Transparency Bill
Senator Chuck Grassley, along with Senator Sherrod Brown and Senator Richard Blumenthal recently introduced bipartisan legislation…
Maine Passes Drug Transparency Law – A Study
We try to keep our readers in the loop with transparency and other related legislation that are happening throughout the country.…
Maine and Colorado: Making Moves on Drug Price Transparency?
We have been keeping up with proposed and passed legislation in several states that affect the pharmaceutical industry, especially…
9th Aggregate Spend and Open Payments Conference
On June 11th and 12th, 2018, the Ninth Aggregate Spend and Open Payments Conference will be held in Philadelphia, Pennsylvania at…
FDA Transparency Blueprint Issued
Most everyone even tangentially related to the pharmaceutical industry knows and understands that right now,…